ID

25803

Description

Testing Strategies to Improving Warfarin Adherence; ODM derived from: https://clinicaltrials.gov/show/NCT00622102

Lien

https://clinicaltrials.gov/show/NCT00622102

Mots-clés

Versions (1)
  1. 20/09/2017 20/09/2017 -
Téléchargé le

20 septembre 2017

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Atrial Fibrillation NCT00622102

Anglais

Eligibility Atrial Fibrillation NCT00622102

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
21 years old age or older
Description

Age

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
on warfarin managed at the ac clinic
Description

on warfarin

Type de données

boolean

Alias
UMLS CUI [1]
C0851145
target inr 2.0-3.0 or 2.5-3.5
Description

Target international normalized ratio

Type de données

boolean

Alias
UMLS CUI [1]
C1272307
at maintenance phase of therapy (defined as stable inr with stable warfarin dosing over at least 2 consecutive visits)
Description

Therapeutic procedure Maintenance Phase | INR Stable | Warfarin Dosage Stable

Type de données

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0024501
UMLS CUI [1,3]
C0205390
UMLS CUI [2,1]
C0525032
UMLS CUI [2,2]
C0205360
UMLS CUI [3,1]
C0043031
UMLS CUI [3,2]
C0178602
UMLS CUI [3,3]
C0205360
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
do not have access to telephone line
Description

Access to telephone Lacking

Type de données

boolean

Alias
UMLS CUI [1,1]
C1822200
UMLS CUI [1,2]
C0332268
unwillingness to participate or to sign a consent form(refusal)
Description

Study Subject Participation Status Unwilling | Informed Consent Refused

Type de données

boolean

Alias
UMLS CUI [1,1]
C2348568
UMLS CUI [1,2]
C0558080
UMLS CUI [2,1]
C0021430
UMLS CUI [2,2]
C1705116
inability to participate because of advances dementia, advanced alzheimer's disease or other impairment affecting ability to provide informed consent and/or quality data or utilize the med-emonitor
Description

Study Subject Participation Status Unable | Dementia Advanced | Alzheimer's Disease Advanced | Impairment Affecting Informed Consent | Impairment Affecting Data Quality | Impairment Affecting Medical care

Type de données

boolean

Alias
UMLS CUI [1,1]
C2348568
UMLS CUI [1,2]
C1299582
UMLS CUI [2,1]
C0497327
UMLS CUI [2,2]
C0205179
UMLS CUI [3,1]
C0002395
UMLS CUI [3,2]
C0205179
UMLS CUI [4,1]
C0221099
UMLS CUI [4,2]
C0392760
UMLS CUI [4,3]
C0021430
UMLS CUI [5,1]
C0221099
UMLS CUI [5,2]
C0392760
UMLS CUI [5,3]
C0242483
UMLS CUI [6,1]
C0221099
UMLS CUI [6,2]
C0392760
UMLS CUI [6,3]
C0496675
participation in a current study that does not permit participation in another study
Description

Study Subject Participation Status Illicit

Type de données

boolean

Alias
UMLS CUI [1,1]
C2348568
UMLS CUI [1,2]
C0332266
end stage or terminal illness with anticipated life expectancy of 6 months or less
Description

Terminal illness | Life Expectancy

Type de données

boolean

Alias
UMLS CUI [1]
C0679247
UMLS CUI [2]
C0023671
inr over the upper limit for the individual's range at the time of enrollment (e.g.,>3.0 or >3.5, depending on the target range)
Description

INR raised

Type de données

boolean

Alias
UMLS CUI [1]
C0853225
diagnosed with antiphospholipid antibody syndrome or abnormal inr prior to starting warfarin
Description

Antiphospholipid Syndrome | INR abnormal

Type de données

boolean

Alias
UMLS CUI [1]
C0085278
UMLS CUI [2]
C0580417
Retour au début de la page

Similar models

Eligibility Atrial Fibrillation NCT00622102

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
21 years old age or older
boolean
C0001779 (UMLS CUI [1])
on warfarin
Item
on warfarin managed at the ac clinic
boolean
C0851145 (UMLS CUI [1])
Target international normalized ratio
Item
target inr 2.0-3.0 or 2.5-3.5
boolean
C1272307 (UMLS CUI [1])
Therapeutic procedure Maintenance Phase | INR Stable | Warfarin Dosage Stable
Item
at maintenance phase of therapy (defined as stable inr with stable warfarin dosing over at least 2 consecutive visits)
boolean
C0087111 (UMLS CUI [1,1])
C0024501 (UMLS CUI [1,2])
C0205390 (UMLS CUI [1,3])
C0525032 (UMLS CUI [2,1])
C0205360 (UMLS CUI [2,2])
C0043031 (UMLS CUI [3,1])
C0178602 (UMLS CUI [3,2])
C0205360 (UMLS CUI [3,3])
Item Group
C0680251 (UMLS CUI)
Access to telephone Lacking
Item
do not have access to telephone line
boolean
C1822200 (UMLS CUI [1,1])
C0332268 (UMLS CUI [1,2])
Study Subject Participation Status Unwilling | Informed Consent Refused
Item
unwillingness to participate or to sign a consent form(refusal)
boolean
C2348568 (UMLS CUI [1,1])
C0558080 (UMLS CUI [1,2])
C0021430 (UMLS CUI [2,1])
C1705116 (UMLS CUI [2,2])
Study Subject Participation Status Unable | Dementia Advanced | Alzheimer's Disease Advanced | Impairment Affecting Informed Consent | Impairment Affecting Data Quality | Impairment Affecting Medical care
Item
inability to participate because of advances dementia, advanced alzheimer's disease or other impairment affecting ability to provide informed consent and/or quality data or utilize the med-emonitor
boolean
C2348568 (UMLS CUI [1,1])
C1299582 (UMLS CUI [1,2])
C0497327 (UMLS CUI [2,1])
C0205179 (UMLS CUI [2,2])
C0002395 (UMLS CUI [3,1])
C0205179 (UMLS CUI [3,2])
C0221099 (UMLS CUI [4,1])
C0392760 (UMLS CUI [4,2])
C0021430 (UMLS CUI [4,3])
C0221099 (UMLS CUI [5,1])
C0392760 (UMLS CUI [5,2])
C0242483 (UMLS CUI [5,3])
C0221099 (UMLS CUI [6,1])
C0392760 (UMLS CUI [6,2])
C0496675 (UMLS CUI [6,3])
Study Subject Participation Status Illicit
Item
participation in a current study that does not permit participation in another study
boolean
C2348568 (UMLS CUI [1,1])
C0332266 (UMLS CUI [1,2])
Terminal illness | Life Expectancy
Item
end stage or terminal illness with anticipated life expectancy of 6 months or less
boolean
C0679247 (UMLS CUI [1])
C0023671 (UMLS CUI [2])
INR raised
Item
inr over the upper limit for the individual's range at the time of enrollment (e.g.,>3.0 or >3.5, depending on the target range)
boolean
C0853225 (UMLS CUI [1])
Antiphospholipid Syndrome | INR abnormal
Item
diagnosed with antiphospholipid antibody syndrome or abnormal inr prior to starting warfarin
boolean
C0085278 (UMLS CUI [1])
C0580417 (UMLS CUI [2])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial